Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

In vivo infection by Trypanosoma cruzi a morphometric study of tissue changes in mice (2013)

  • Authors:
  • USP affiliated authors: BASTOS, JAIRO KENUPP - FCFRP ; ALBUQUERQUE, SÉRGIO DE - FCFRP
  • USP Schools: FCFRP; FCFRP
  • DOI: 10.1007/s00436-012-3048-x
  • Subjects: TRYPANOSOMA CRUZI (PATOGENICIDADE); ANTIPROTOZOÁRIOS (EFEITOS ADVERSOS); MODELOS ANIMAIS DE DOENÇAS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00436-012-3048-x (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Parasitology Research

    ISSN: 0932-0113

    Citescore - 2017: 2.46

    SJR - 2017: 0.991

    SNIP - 2017: 1.001


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FCFRP2411668pcd 2411668 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ESPERANDIM, Viviane Rodrigues; FERREIRA, Daniele da Silva; REZENDE, Karen Cristina Sousa; et al. In vivo infection by Trypanosoma cruzi a morphometric study of tissue changes in mice. Parasitology Research, Heidelberg, v. 112, n. 1, p. 431-436, 2013. Disponível em: < http://dx.doi.org/10.1007/s00436-012-3048-x > DOI: 10.1007/s00436-012-3048-x.
    • APA

      Esperandim, V. R., Ferreira, D. da S., Rezende, K. C. S., Cunha, W. R., Saraiva, J., Bastos, J. K., et al. (2013). In vivo infection by Trypanosoma cruzi a morphometric study of tissue changes in mice. Parasitology Research, 112( 1), 431-436. doi:10.1007/s00436-012-3048-x
    • NLM

      Esperandim VR, Ferreira D da S, Rezende KCS, Cunha WR, Saraiva J, Bastos JK, Silva MLA e, Albuquerque S de. In vivo infection by Trypanosoma cruzi a morphometric study of tissue changes in mice [Internet]. Parasitology Research. 2013 ; 112( 1): 431-436.Available from: http://dx.doi.org/10.1007/s00436-012-3048-x
    • Vancouver

      Esperandim VR, Ferreira D da S, Rezende KCS, Cunha WR, Saraiva J, Bastos JK, Silva MLA e, Albuquerque S de. In vivo infection by Trypanosoma cruzi a morphometric study of tissue changes in mice [Internet]. Parasitology Research. 2013 ; 112( 1): 431-436.Available from: http://dx.doi.org/10.1007/s00436-012-3048-x

    Referências citadas na obra
    Andrade SG (1976) Tentative for grouping different Trypanosoma cruzi strains in some types. Rev Inst Med Trop Sao Paulo 18:140–144
    Bastos JK, Albuquerque S, Silva MLA (1999) Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo. Planta Med 65:1–4
    Buckner FS, Verlinde CMJ, Flamme AC, Van Voorhis WC (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob Agents Chemother 40:2592–2597
    Castro JA, Mecca MM, Bartel LC (2006) Toxic side effects of drugs used to treat Chagas’ disease (American trypanosomiasis). Human Exp Toxicol 25:471–479
    Coura JR, Dias JCP (2009) Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz 104:31–40
    da Silva R, de Souza GH, da Silva AA, de Souza VA, Pereira AC, Royo VA, Silva ML, Donate PM, de Matos Araujo AL, Carvalho JC, Bastos JK (2005) Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin. Bioorg Med Chem Lett 15:1033–1037
    de Souza VA, Silva R, Pereira AC, Royo VA, Saraiva J, Montanheiro M, Souza GHB, Filho AAS, Grando MD, Donate PM, Bastos JK, Albuquerque S, Silva MLA (2005) Trypanocidal activity of (−)- cubebin derivatives against free amastigote forms of Trypanosoma cruzi. Bioorg Med Chem Lett 15:303–307
    Esperandim VR, Ferreira DS, Saraiva J, Silva ML, Costa ES, Pereira AC, Bastos JK, de Albuquerque S (2010) Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones. Parasitol Res 107:525–3
    Izumi E, Ueda-Nakamura T, Dias Filho BP, Veiga Júnior VF, Nakamura CV (2011) Natural products and Chagas’ disease: a review of plant compounds studied for activity against Trypanosoma cruzi. Nat Prod Rep 23:809–823
    Kayser O, Kiderlen AF, Croft SL (2003) Natural products as antiparasitic drugs. Parasitol Res 90:55–62
    Marín-Neto JA, Rassi AJR (2009) Update on Chagas heart disease on the first centenary of its discovery. Rev Esp Cardiol 62:1211–1216
    Maya JD, Bollo S, Núnez-Vergara LJ, Squella JA, Repeppo Y, Morello A, Perie J, Chauviere G (2003) Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives. Biochem Pharmacol 65:999–1006
    Maya JD, Cassels BK, Iturriaga-Vasquez P, Ferreira J, Fagundez M, Galanti N, Ferreira A, Morello A (2007) Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp Biochem Physiol A Mol Integr Physiol 146:601–620
    Montanari CA, Bolzani VS (2001) Planejamento racional de fármacos baseado em produtos naturais. Quim Nova 24:105–111
    Rassi AJR, Rassi A, Marin-Nepo JA (2009) Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz 104:152–158
    Sala MA, Lopes RA, Abrahão AAC, Meneguette C, Albuquqerque S, Ribeiro RD (2008) Estudio cariométrico de placentas de ratones com infección aguda por diferentes cepas de Trypanosoma cruzi. Intern J Morphol 26:623–627
    Saraiva J, Vega C, da Silva R, Silva MLA, Donate PM, Bastos JK, Gomes-Barrio A, Albuquerque S (2007) In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi. Parasitol Res 100:791–795
    Silva R, de Souza GHB, da Silva AA, de Souza VA, Pereira AC, Royo VA, Silva MLA, Donate PM, Matos ALS, Carvalho JCT, Bastos JK (2005) Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin. Bioorg Med Chem Lett 15:1033–1039
    Soares MBP, Ribeiro dos Santos R (1999) Immunopathology of cardiomyopathy in the experimental Chagas disease. Mem Inst Oswaldo Cruz 94:257–262
    Tanowitz HB, Machado FS, Jelicks LA, Shirani J, de Carvalho AC, Spray DC, Factor SM, Kirchhoff LV, Weiss LM (2009) Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 51:524–539
    Urbina JA (2009) Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 115:55–68
    Usia T, Watabe T, Kadota S, Tezuka Y (2005) Metabolite-cytochrome P450 complex formation by methylenedioxyphenyl lignans of Piper cubeba: mechanism-based inhibition. Life Sci 76:2381–2391
    Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Armenti A (2009) Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev Anti Infect Ther 7:157–163
    WHO-World Health Organization (2007) Control of Chagas disease. (WHO’s certified database on the Internet). Available from: http://whqlibdoc.who.int/trs/WHO_TRS_905.pdf . (cited 2011 Mar 15)